Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
3 papers
This report describes 33 open-label treatments with the alkaloid ibogaine given for acute heroin withdrawal in non-medical settings. In 25 of the 33 people, visible signs of opioid withdrawal stopped within 24 hours and stayed absent during 72 hours of observation. The authors note the results are from uncontrolled, non-clinical…
This report describes informal ibogaine treatments given in a small program. In 24 sessions (18 aimed at addiction), a single ibogaine dose often stopped physical opioid withdrawal and created a window when people felt more able to choose. Some people stayed drug-free for months or years, but many relapsed and…
This case report describes a 68-year-old woman with fibromyalgia and other chronic pain that had not improved with standard treatments. She received seven increasing intravenous (IV) ketamine doses over two weeks, then continued IV ketamine twice weekly for more than a year. While on this schedule she reported marked, widespread…
